Evidence map›Paper›PMID 30526619›Full record

ArticleMalaria journal2018

Evaluating the quality of routinely reported data on malaria commodity stocks in Guinea, 2014-2016.

Yu Sun, Timothée Guilavogui, Alioune Camara, Mohamed Dioubaté, Babacar Deen Toure, Claude Bahati, Marie Paule Fargier, Jessica Butts, Patrick Condo, Abdoulaye Sarr and 1 more

Abstract read
In one paragraph

Article in Malaria journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yu SunRollins School of Public Health, Emory University, Atlanta, GA, USA.
Timothée GuilavoguiNational Malaria Control Program, Conakry, Guinea.
Alioune CamaraNational Malaria Control Program, Conakry, Guinea.
Mohamed DioubatéNational Malaria Control Program, Conakry, Guinea.
Babacar Deen ToureNational Malaria Control Program, Conakry, Guinea.
Claude BahatiSystems for Improved Access to Pharmaceuticals and Services, Conakry, Guinea.
Marie Paule FargierSystems for Improved Access to Pharmaceuticals and Services, Conakry, Guinea.
Jessica ButtsMalaria Branch, Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Patrick CondoU.S. President's Malaria Initiative, USAID, Conakry, Guinea.
Abdoulaye SarrMalaria Branch, Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Mateusz M PlucinskiMalaria Branch, Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, GA, USA. mplucinski@cdc.gov.ORCID http://orcid.org/0000-0002-7322-4625

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEnsuring malaria commodity availability at health facilities is a cornerstone of malaria control. Since 2013, the Guinea National Malaria Control Programme has been routinely collecting data on stock levels of key malaria commodities through a monthly routine malaria information system (RMIS). In parallel, biannual end-user verification (EUV) surveys have also assessed malaria commodity availability at a subset of health facilities, potentially representing a duplication of efforts.

methodsData on 12 malaria commodity stock levels verified during four EUV surveys conducted between 2014 and 2016 was compared to data for the corresponding months submitted by the same health facilities through the RMIS. The sensitivity and specificity of the RMIS in detecting stock-outs was calculated, as was the percent difference between average stock levels reported through the two systems.

resultsOf the 171 health facilities visited during the four EUV surveys, 129 (75%) had data available in the RMIS. Of 351 commodity stock-outs observed during the EUV in the sampled reporting health facilities, 256 (73%) were also signaled through the corresponding RMIS reports. When the presence of malaria commodity stocks was confirmed during the EUV surveys, the RMIS also reported available stock 87% (677/775) of the time. For all commodities, the median percent difference in average stock levels between the EUV and RMIS was 4% (interquartile range - 7 to 27%).

conclusionThe concordance between stock levels reported through the RMIS and those verified during the EUV visits provides certain evidence that RMIS data can inform quantification and procurement decisions. However, lower than acceptable rates of reporting and incomplete detection of stock-outs from facilities that do report suggest that further systems strengthening is needed to improve RMIS reporting completeness and data quality.

Indexed as

AntimalarialsArtemisininsData AccuracyGuineaHealth Services AccessibilityHumansMalariaRetrospective StudiesAntimalarialsArtemisininsArtemisinin-based combination therapyData qualityLogistics management information systemRapid diagnostic testStock-out

Identifiers

PMID30526619
PMCPMC6286573

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.